Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on C Acid. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN113135971A details a high-yield synthesis of carbon-losing cholestanal from duck cholic acid, offering a cost-effective route for API intermediates.
Advanced synthesis method for high-purity 3,4-dimethoxy benzenpropanoic acid. Enhances supply chain reliability and reduces environmental impact for pharmaceutical manufacturing.
Patent CN101735167B reveals a green synthesis route for 6-nitrosaccharin, offering cost reduction in agrochemical intermediate manufacturing and superior supply chain reliability.
Advanced etherification of 3-hydroxymethyl cephalosporins using dioxycarbenium tetrafluoroborate. Superior yield, reduced lactone impurities, and scalable manufacturing solutions.
Patent CN102211995A reveals an efficient ethanol-based synthesis for 2,6-dihydroxybenzoic acid, offering reduced energy consumption and superior yield for agrochemical manufacturing.
Patent CN106045883A reveals a novel metal-chelation route for Fmoc-Asp-OtBu, offering significant cost reduction and enhanced supply chain reliability for peptide synthesis.
Patent CN108409626A details a novel route for Rucaparib intermediates offering enhanced purity and cost efficiency for global pharmaceutical supply chains.
Patent CN105111073A details a high-yield synthesis for Higher Alkanol Gallate. Discover cost-effective production and supply chain advantages for food additives.
Patent CN103193654A reveals a high-yield metalloporphyrin catalytic oxidation process for o-nitrobenzoic acid, offering significant cost reduction and supply chain efficiency for pharmaceutical intermediates.
Patent CN115197161B details novel palladium catalysis for Z-configuration amino acids. Enables cost reduction and supply chain reliability for pharmaceutical intermediates manufacturing.
Patent CN106928055B reveals green aspirin synthesis. Choline-based solvents offer cost reduction and supply chain reliability for pharmaceutical intermediates manufacturing.
Novel aqueous phase synthesis of dimethyloxamonoamide for nuclear waste treatment. High yield, simplified process, and cost-effective manufacturing solutions.
Patent CN111072734A reveals a high-yield route to Doxifluridine using a styryl-benzoate ribose donor, offering mild conditions and 98% coupling efficiency for API manufacturing.
Patent CN118652170A enables high-yield synthesis of Dapagliflozin intermediates with reduced waste and cost for global supply chains.
Novel Grignard exchange method achieves >99.5% purity and >80% yield for pharmaceutical intermediates, offering significant cost and supply chain advantages.
Patent CN104031009B enables high optical purity tetrahydrofuran-2-carboxylic acids via benzylamine resolution. Offers cost reduction and supply chain reliability for pharmaceutical intermediates manufacturing.
Novel resolution method using L-Tyrosine methyl ester achieves >99.5% ee. Cost-effective, scalable process for pharmaceutical intermediates.
Efficient 4-step synthesis of Mycophenolic acid-13CD3 via Mitsunobu reaction. Cost-effective route for pharmacokinetic research intermediates.
Patent CN101066924B reveals a streamlined chemical synthesis for Orlistat intermediates, offering high purity and scalable production for pharmaceutical manufacturers.
Advanced biocatalytic synthesis of betulinic acid using ionic liquids. Enhances yield and supply chain reliability for pharmaceutical intermediates.